E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/3/2006 in the Prospect News Biotech Daily.

Boston Scientific gets FDA clearance for new catheter tube

By Elaine Rigoli

Tampa, Fla., April 3 - Boston Scientific Corp. launched its Super Sheath Introducer Sheath, which has received clearance from the Food and Drug Administration, for use in the introduction of interventional and diagnostic devices inserted in the human vasculature.

The Super Sheath Introducer Sheath, a tube that is placed inside a vessel during an interventional procedure to help with catheter placement, offers several design enhancements, according to a news release.

The smooth wire-to-dilator-to-sheath transition is designed to facilitate insertion, to support ease of entry and reduced vessel trauma. The rotating suture wing and translucent hub allow for efficient operation.

A silicone-coated valve and the sheath's smooth inner surface promote easy device passage, and radiopaque markers aid in precise device placement, the release said.

"The introduction of Super Sheath Introducer Sheath - along with the recent launch of our ZIPwire Guide Wire - further demonstrates our commitment to providing physicians with superior tools for peripheral and coronary interventions," said Hank Kucheman, president of Boston Scientific's interventional cardiology business, in a news release.

"These technologies are designed to facilitate access to vascular lesions and help to improve the efficiency and outcomes of minimally invasive procedures," he added.

Boston Scientific, based in Natick, Mass., develops products for a broad range of interventional medical specialties.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.